The Second Affiliated Hospital Of Kunming Medical University
Clinical trials sponsored by The Second Affiliated Hospital Of Kunming Medical University, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New Triple-Drug strategy aims to boost remission in Hard-to-Treat leukemia Results expected Dec 2026 (estimated)
-
Can a shorter drug combo improve outcomes for older AML patients?
Disease control CompletedResearchers are testing whether a combination of venetoclax and a three-day course of decitabine works better than the standard pairing of venetoclax and azacitidine for older or unfit adults newly diagnosed with acute myeloid leukemia. The trial enrolls 154 participants and comp…
Phase 3 • Sponsor: The Second Affiliated Hospital of Kunming Medical University • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Gentle zap during thyroid surgery may save Patients' voices
Disease control CompletedThis study tests whether using a low electrical current (3 or 5 milliamps) during thyroid surgery helps surgeons locate and avoid damaging the nerve that controls the voice box. About 150 adults having their first thyroid surgery will be randomly assigned to one of two current le…
Sponsor: The Second Affiliated Hospital of Kunming Medical University • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC